• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab.1例新型冠状病毒肺炎患者慢性自发性荨麻疹加重：对奥马珠单抗反应迅速且效果良好
Int J Dermatol. 2020 Oct;59(10):1294-1295. doi: 10.1111/ijd.15134. Epub 2020 Aug 17.
2
Real-world dosing of omalizumab for chronic spontaneous urticaria.奥马珠单抗治疗慢性自发性荨麻疹的真实世界用药情况。
Ann Allergy Asthma Immunol. 2020 Feb;124(2):211-212. doi: 10.1016/j.anai.2019.11.028. Epub 2019 Dec 2.
3
Concomitant treatment with omalizumab and cyclosporine for chronic spontaneous urticaria.奥马珠单抗与环孢素联合治疗慢性自发性荨麻疹。
Ann Allergy Asthma Immunol. 2020 Jul;125(1):111-112. doi: 10.1016/j.anai.2020.04.020. Epub 2020 Apr 29.
4
Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy.病例报告：奥马珠单抗治疗妊娠期慢性自发性荨麻疹。
Front Immunol. 2021 Mar 16;12:652973. doi: 10.3389/fimmu.2021.652973. eCollection 2021.
5
COVID-19 infection under omalizumab therapy for chronic spontaneous urticaria: three cases.奥马珠单抗治疗慢性自发性荨麻疹期间发生新型冠状病毒肺炎感染：三例报告
Int J Dermatol. 2021 Feb;60(2):253-254. doi: 10.1111/ijd.15379. Epub 2020 Dec 17.
6
A severe adverse reaction to omalizumab therapy in chronic spontaneous urticaria.慢性自发性荨麻疹患者接受奥马珠单抗治疗时出现的严重不良反应。
Dermatol Ther. 2020 Jan;33(1):e13204. doi: 10.1111/dth.13204. Epub 2019 Dec 28.
7
Omalizumab for chronic spontaneous urticaria in "complex" patients: data from real-life clinical practice.奥马珠单抗用于“复杂”患者的慢性自发性荨麻疹：来自真实临床实践的数据
Drug Des Devel Ther. 2019 Sep 6;13:3181-3186. doi: 10.2147/DDDT.S214307. eCollection 2019.
8
A patient-oriented approach to long-term use of omalizumab in chronic spontaneous urticaria.以患者为中心的奥马珠单抗长期治疗慢性自发性荨麻疹。
Cutan Ocul Toxicol. 2021 Dec;40(4):305-311. doi: 10.1080/15569527.2021.1945618. Epub 2021 Jul 2.
9
Determinants of omalizumab drug survival in a long-term daily practice cohort of patients with chronic urticaria.慢性荨麻疹患者长期日常实践队列中奥马珠单抗药物留存率的决定因素
Allergy. 2019 Jun;74(6):1185-1187. doi: 10.1111/all.13714. Epub 2019 Jan 25.
10
The impact of omalizumab on quality of life and its predictors in patients with chronic spontaneous urticaria: Real-life data.奥马珠单抗对慢性自发性荨麻疹患者生活质量的影响及其预测因素：真实世界数据。
Dermatol Ther. 2019 Jul;32(4):e12975. doi: 10.1111/dth.12975. Epub 2019 Jun 25.

引用本文的文献

1
COVID-19 infection in chronic spontaneous urticaria treated with omalizumab: two case reports.奥马珠单抗治疗慢性自发性荨麻疹合并新型冠状病毒肺炎感染：两例病例报告
Dermatol Reports. 2023 Jul 16;16(2):9763. doi: 10.4081/dr.2023.9763. eCollection 2024 Jun 14.
2
COVID-19 Immunologic Antiviral Therapy With Omalizumab (CIAO)-a Randomized Controlled Clinical Trial.使用奥马珠单抗的COVID-19免疫抗病毒疗法（CIAO）——一项随机对照临床试验
Open Forum Infect Dis. 2024 Feb 23;11(4):ofae102. doi: 10.1093/ofid/ofae102. eCollection 2024 Apr.
3
A case of acute exacerbation of chronic spontaneous urticaria due to COVID-19 immediately after omalizumab administration.一例在使用奥马珠单抗后立即因新型冠状病毒肺炎导致慢性自发性荨麻疹急性加重的病例。
Postepy Dermatol Alergol. 2022 Dec;39(6):1171-1173. doi: 10.5114/ada.2022.122609. Epub 2022 Dec 22.
4
Omalizumab may protect allergic patients against COVID-19: A systematic review.奥马珠单抗可能保护过敏患者预防新型冠状病毒肺炎：一项系统评价。
World Allergy Organ J. 2023 Feb;16(2):100741. doi: 10.1016/j.waojou.2023.100741. Epub 2023 Jan 9.
5
Safely use of omalizumab during SARS-CoV-2 infection in patients with chronic spontaneous urticaria.慢性自发性荨麻疹患者在感染SARS-CoV-2期间安全使用奥马珠单抗。
J Cosmet Dermatol. 2023 Jan;22(1):26-27. doi: 10.1111/jocd.15544. Epub 2022 Nov 30.
6
Navigating patients with atopic dermatitis or chronic spontaneous urticaria during the COVID-19 pandemic.在新冠疫情期间为特应性皮炎或慢性自发性荨麻疹患者提供指导。
Front Allergy. 2022 Oct 4;3:809646. doi: 10.3389/falgy.2022.809646. eCollection 2022.
7
COVID-19  vaccination in patients receiving allergen immunotherapy (AIT) or biologicals-EAACI recommendations.COVID-19 疫苗接种在接受过敏原免疫治疗（AIT）或生物制剂治疗的患者中的应用——EAACI 建议。
Allergy. 2022 Aug;77(8):2313-2336. doi: 10.1111/all.15252. Epub 2022 Mar 18.
8
Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and Outcome.抗2型炎症生物疗法对COVID-19临床病程及结局的影响
J Inflamm Res. 2021 Dec 14;14:6845-6853. doi: 10.2147/JIR.S345665. eCollection 2021.
9
The overall impact of COVID-19 on healthcare during the pandemic: A multidisciplinary point of view.新冠疫情期间COVID-19对医疗保健的总体影响：多学科视角
Health Sci Rep. 2021 Oct 1;4(4):e386. doi: 10.1002/hsr2.386. eCollection 2021 Dec.
10
COVID-19 Disease Leading to Chronic Spontaneous Urticaria Exacerbation: A Romanian Retrospective Study.新冠病毒疾病导致慢性自发性荨麻疹病情加重：一项罗马尼亚的回顾性研究。
Healthcare (Basel). 2021 Sep 1;9(9):1144. doi: 10.3390/healthcare9091144.

本文引用的文献

1
Early Insights into Immune Responses during COVID-19.对 COVID-19 期间免疫反应的早期洞察。
J Immunol. 2020 Aug 1;205(3):555-564. doi: 10.4049/jimmunol.2000526. Epub 2020 Jun 8.
2
Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.肥大细胞在冠状病毒诱导的炎症中起作用：新的抗炎策略。
J Biol Regul Homeost Agents. 2020;34(1):9-14. doi: 10.23812/20-Editorial-Kritas.
3
Response of FcεRI-bearing leucocytes to omalizumab in chronic spontaneous urticaria.奥马珠单抗治疗慢性自发性荨麻疹患者嗜碱性粒细胞和嗜酸性粒细胞FcεRI 表达的变化。
Clin Exp Allergy. 2020 Mar;50(3):364-371. doi: 10.1111/cea.13566. Epub 2020 Feb 7.
4
Association between urticaria and virus infections: A systematic review.荨麻疹与病毒感染之间的关联：一项系统综述。
Allergy Asthma Proc. 2016 Jan-Feb;37(1):18-22. doi: 10.2500/aap.2016.37.3915. Epub 2015 Dec 3.
5
Urticaria associated with Norovirus infection: report of two cases.诺如病毒感染相关的荨麻疹：两例报告。
J Dtsch Dermatol Ges. 2008 Jul;6(7):563-5. doi: 10.1111/j.1610-0387.2007.06501.x.

Chronic spontaneous urticaria exacerbation in a patient with COVID-19: rapid and excellent response to omalizumab.

作者信息

Criado Paulo R, Criado Roberta F J, Pincelli Thais P, Yoshimoto Thais A, Naufal Gabriela G A, Abdalla Beatrice M Z

机构信息

Dermatology Department, Centro Universitário Saúde ABC (Faculdade de Medicina do ABC), An UCARE Center, Santo André, Brazil.

Alergoskin Alergia e Dermatologia, An UCARE Center, Santo André, Brazil.

出版信息

Int J Dermatol. 2020 Oct;59(10):1294-1295. doi: 10.1111/ijd.15134. Epub 2020 Aug 17.

DOI:10.1111/ijd.15134
PMID:32808279
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7461406/
Abstract
摘要